PMID: 39694701

Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8 + CD69 + T cells.

Tang Shichuan, Tang Ruijing, Chen Geng, Zhang Da, Lin Kongying, Yang Huan, Fu Jun, Guo Yutong, Lin Fangzhou, Dong Xiuqing

Journal for immunotherapy of cancer · 2024

Vol. 12, Issue 12

View on PubMed DOI

This entry links to third-party literature. For research use only.

AnimalsLiver NeoplasmsMiceHumansCancer VaccinesCD8-Positive T-LymphocytesProgrammed Cell Death 1 ReceptorCTLA-4 AntigenImmune Checkpoint InhibitorsFemale

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.